Vanesa Sekeruš
Assistant Professor
vanesa.sekerus@mf.uns.ac.rs
Phone:
ORCID ID : 0000-0002-4785-7891
vanesa.sekerus@mf.uns.ac.rs
Phone:
ORCID ID : 0000-0002-4785-7891
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2024 |
Faculty of Medicine Novi Sad |
Biochemistry | Graduated |
2011 |
Faculty of Medicine Novi Sad |
Pharmacy |
| M | Description |
|---|---|
22 | Perin J, Zarić B, Đođić JE, Potić Z, Potić M, Sekeruš V, et al. The cost of hospital treatment of advanced stage lung cancer patients in a developing South East European country. J Cancer. 2018;9(17):3038-45. |
22 | Zaric B, Stojsic V, Panjkovic M, Tegeltija D, Stepanov V, Kovacevic T, et al. Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population. J Cancer. 2016;7(15):2207-12. |
23 | Stepanov V, Stankov K, Mikov M. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J Recept Signal Transduct Res. 2013;33(4):213-23. |
51 | Stojčević Maletić J, Bačulov K, Sekeruš V, Vučinić N, Milanović B, Barjaktarović I. Detection of alpha-1 antitrypsin gene mutations by polymerase chain reaction in patients with chronic obstructive pulmonary disease. Med Pregl 2019; LXXII (5-6): 148-53. |
52 | Pupavac U, Tegeltija D, Lovrenski A, Sekeruš V, Maksimović S, Bijelović M, Oluški D. Clinical and pathological characteristics of malignant pleural mesothelioma – our five year experience. MD-Medical Data. 2019;11(1):019-22. |
52 | Popovic DS, Sekerus V. Levels of different adipocytokines in chronic complications of type 1 diabetes mellitus. Integr Obesity Diabetes. 2016;2(4):255-61. |
52 | Tegeltija D, Lovrenski A, Vasiljević T, Sekeruš V, Maksimović S, Kuhajda I, et al. Da li je histološka građa adenocarcinoma pluća u dijagnostičkim i terapijskim uzorcima identična? Respiratio. 2019;9(1-2):30-5. |
34 | Sekeruš V, Stojanović G, Bursać D, Tegeltija D, Stolić M, Andrijević I. Cell-free circulating tumor DNA in plasma of non-small cell lung cancer patients: The role in EGFR T790M mutation testing. EuroMedLab 2019. Barcelona, Spain, May 19-23. Clinica Chimica Acta. 2019;493S1:S563-83,W286. |
34 | Sekeruš V, Eri Ž, Bursać D, Stolić M, Tegeltija D, Lovrenski A, et al. EGFR T790M resistance mutation in non-small-cell lung cancer: our experience in liquid biopsy and molecular testing. 17th Central European Lung Cancer Conference including Best of WCLC 2018. Novi Sad, Serbia, November 30-December 2, 2018. Abstract book, p39. |
34 | Lovrenski A, Tegeltija D, Sekeruš V, Vučković D, Eri Ž. Application of the 8th revision of TNM classification of lung carcinoma. 17th Central European Lung Cancer Conference including Best of WCLC 2018. Novi Sad, Serbia, November 30-December 2, 2018. Abstract book, p31. |
| Course | Studies |
|---|---|
Medical biochemistry and chemistry | Integrated Academic Studies of Medicine |
Biochemistry | Integrated Academic Studies of Dentistry |
General Biochemistry | Integrated Academic Studies of Pharmacy |
Medical Biochemistry | Integrated Academic Studies of Pharmacy |
Biochemistry | Undergraduate Academic Studies of Nursing |
Biochemistry | Undergraduate Applied Studies of Nursing |